Holst-Hansen T - Search Results

1

The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies.

Kral P, Holst-Hansen T, Olivieri AV, Ivanescu C, Lamotte M, Larsen S. Kral P, et al. Among authors: holst hansen t. Adv Ther. 2024 Nov;41(11):4228-4247. doi: 10.1007/s12325-024-02932-8. Epub 2024 Sep 24. Adv Ther. 2024. PMID: 39316288 Free PMC article.

2

Tipping-point transition from transient to persistent inflammation in pancreatic islets.

Holst-Hansen T, Nielsen PY, Jensen MH, Mandrup-Poulsen T, Trusina A. Holst-Hansen T, et al. NPJ Syst Biol Appl. 2024 Sep 12;10(1):102. doi: 10.1038/s41540-024-00427-4. NPJ Syst Biol Appl. 2024. PMID: 39266581 Free PMC article.

3

The association between body mass index and health-related quality of life in the 2017 and 2018 health survey of England data: A cross-sectional observational analysis.

Luah XW, Holst-Hansen T, Lübker C. Luah XW, et al. Among authors: holst hansen t. Diabetes Obes Metab. 2024 Jun;26(6):2318-2328. doi: 10.1111/dom.15546. Epub 2024 Mar 18. Diabetes Obes Metab. 2024. PMID: 38499493

4

Treatment effect of semaglutide 2.4 mg on health-related quality of life from STEP 1 SF-6D derived from SF-36 with Australian weights.

Kral P, Allen FL, Larsen S, Holst-Hansen T, Olivieri AV, Manton A. Kral P, et al. Among authors: holst hansen t. Diabetes Obes Metab. 2024 Apr;26(4):1171-1179. doi: 10.1111/dom.15426. Epub 2024 Jan 9. Diabetes Obes Metab. 2024. PMID: 38195847

5

Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity.

Wilkinson L, Holst-Hansen T, Laursen PN, Rinnov AR, Batterham RL, Garvey WT. Wilkinson L, et al. Among authors: holst hansen t. Obesity (Silver Spring). 2023 Sep;31(9):2249-2259. doi: 10.1002/oby.23842. Obesity (Silver Spring). 2023. PMID: 37605636 Clinical Trial.

6

Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.

Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, Rubino DM, Garvey WT; OASIS 1 Investigators. Knop FK, et al. Among authors: holst hansen t. Lancet. 2023 Aug 26;402(10403):705-719. doi: 10.1016/S0140-6736(23)01185-6. Epub 2023 Jun 26. Lancet. 2023. PMID: 37385278 Clinical Trial.

7

The improved health utility of once-weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1-4 obesity trials.

Bjorner JB, Larsen S, Lübker C, Holst-Hansen T. Bjorner JB, et al. Among authors: holst hansen t. Diabetes Obes Metab. 2023 Aug;25(8):2142-2150. doi: 10.1111/dom.15090. Epub 2023 May 8. Diabetes Obes Metab. 2023. PMID: 37055712 Clinical Trial.

8

Spatiotemporal NF-κB dynamics encodes the position, amplitude, and duration of local immune inputs.

Son M, Frank T, Holst-Hansen T, Wang AG, Junkin M, Kashaf SS, Trusina A, Tay S. Son M, et al. Among authors: holst hansen t. Sci Adv. 2022 Sep 2;8(35):eabn6240. doi: 10.1126/sciadv.abn6240. Epub 2022 Aug 31. Sci Adv. 2022. PMID: 36044569 Free PMC article.

9

Impact of Zygosity on Bimodal Phenotype Distributions.

Holst-Hansen T, Abad E, Muntasell A, López-Botet M, Jensen MH, Trusina A, Garcia-Ojalvo J. Holst-Hansen T, et al. Biophys J. 2017 Jul 11;113(1):148-156. doi: 10.1016/j.bpj.2017.05.010. Biophys J. 2017. PMID: 28700913 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters